QuidelOrtho Corp. (QDEL)
29.66
+0.86
(+3.00%)
USD |
NASDAQ |
Dec 11, 16:00
29.57
-0.09
(-0.30%)
After-Hours: 20:00
QuidelOrtho Research and Development Expense (Quarterly): 41.50M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 514.00M |
| Intuitive Surgical, Inc. | 329.40M |
| West Pharmaceutical Services, Inc. | 17.10M |
| iRhythm Technologies, Inc. | 21.03M |
| Perspective Therapeutics, Inc. | 19.56M |